GCIA
DICE

Gabelli & Co Investment Advisers’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-107,250
Closed -$4.98M – 289
2023
Q2 		$4.98M Buy
+107,250
New +$3.71M 0.83% 31

Gabelli & Co Investment Advisers's DICE Position: Q3 2023 in Review

Gabelli & Co Investment Advisers sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 107,250 shares — an estimated $4.98M sold.

Gabelli & Co Investment Advisers first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $4.98M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Gabelli & Co Investment Advisers reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 107,250 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $4.98M.
  • Gabelli & Co Investment Advisers first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's DICE Therapeutics, Inc. Common Stock position peaked at $4.98M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2023, filed 8 Nov 2023.